financetom
Business
financetom
/
Business
/
Global Blue Fiscal Q3 Adjusted Net Income, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Global Blue Fiscal Q3 Adjusted Net Income, Revenue Rise
Feb 26, 2025 4:13 AM

06:53 AM EST, 02/26/2025 (MT Newswires) -- Global Blue ( GB ) reported fiscal Q3 adjusted net income Wednesday of 14.4 million euros ($15.1 million), up from 9.1 million euros a year earlier.

Revenue for the quarter ended Dec. 31 was 131.4 million euros, compared with 109.4 million euros a year earlier.

A single analyst surveyed by FactSet expected 129.2 million euros.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Donald Trump Set to Receive Windfall Payout if Trump Media & Technology Stock Remains Above $17.50
Donald Trump Set to Receive Windfall Payout if Trump Media & Technology Stock Remains Above $17.50
Apr 23, 2024
09:29 AM EDT, 04/23/2024 (MT Newswires) -- Trump Media & Technology Group's ( DJT ) majority owner Donald Trump is set for a windfall payout, assuming the stock doesn't lose more than half its value by the end of trading on Tuesday. According to Securities and Exchange Commission filings, Trump will receive an additional 36 million shares if the average...
US oil and gas M&A hits quarterly record after blockbuster 2023
US oil and gas M&A hits quarterly record after blockbuster 2023
Apr 23, 2024
* Diamondback's bid for Endeavor tops 1Q deal rankings * Top US shale field remains focus of energy M&A activity HOUSTON, April 23 (Reuters) - U.S. oil and gas deals hit a record $51 billion in the first quarter, a continuation of last year's fierce merger pace centered in the top U.S. shale field, data provider Enverus said on Tuesday....
ImmunityBio Gaining in Tuesday Pre-Market after FDA Approval for Anktiva-Bacterium Combination for Bladder Cancer
ImmunityBio Gaining in Tuesday Pre-Market after FDA Approval for Anktiva-Bacterium Combination for Bladder Cancer
Apr 23, 2024
09:27 AM EDT, 04/23/2024 (MT Newswires) -- ImmunityBio ( IBRX ) rose more than 23% in recent premarket activity on Tuesday after the US Food and Drug Administration approved a combination of the company's Anktiva immunotherapy and the Bacillus Calmette-Guerin bacterium in patients with a form of non-muscle invasive bladder cancer that previously was unresponsive to BGC therapy. The FDA...
NVR's Q1 Earnings, Revenue Rise
NVR's Q1 Earnings, Revenue Rise
Apr 23, 2024
09:26 AM EDT, 04/23/2024 (MT Newswires) -- NVR (NVR) reported Q1 earnings Tuesday of $116.41 per diluted share, up from $99.89 a year earlier. Analysts polled by Capital IQ expected $103.76. Revenue for the quarter ended March 31 was $2.29 billion, up from $2.13 billion a year earlier. Analysts surveyed by Capital IQ expected $2.25 billion. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved